Clinical Trial Update: Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea [Phase 1]

View source ↗

Summary

A Phase 1 comparative effectiveness trial for pediatric plaque morphea sponsored by the Medical College of Wisconsin has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Scleroderma
• Scleroderma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Scleroderma | Phase 1 | Status: WITHDRAWN